title: Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy.
abstract: OBJECTIVE
  The prognosis of non-small-cell lung cancer (NSCLC) patients with malignant pleural disease (MPD), characterized by malignant pleural effusion and/or malignant pleural nodules, is reported to be poor, and patients with MPD are generally not subjected to surgery. However, whether or not the primary tumor should be resected, when MPD is first detected at thoracotomy, is controversial.
  
  
  METHODS
  The clinical records of 1623 consecutive NSCLC patients, who underwent surgery between 1990 and 2007, were retrospectively reviewed. A hundred patients (6.2%) were classified with pathological stage IV disease according to the seventh edition of the Union for International Cancer Control (UICC) staging system. There were 73 patients with MPD, which included 32 with effusion without nodules (MPE) and 41 with nodules with or without effusion (MPN). Intra- or postoperative pleural chemotherapy was administered to 37 MPD patients.
  
  
  RESULTS
  The median survival time, the 3-year survival rate and the 5-year survival rate for MPD patients were 25.9 months, 41.4%, and 23.7%, respectively, which are better outcomes than those for M1b patients (8.7 months, 18% and 18%, respectively) (log-lank test: p=0.014). Among MPD patients, N0-1 disease was determined to be a favorable prognostic factor (p=0.01). MPD status (MPE or MPN) was not prognostically significant (p=0.40). MPE patients with N0-1 disease had a significantly better prognosis with a 5-year survival rate of 63.6% compared to MPE patients with N2-3 disease (p=0.003). Twenty-seven percent of MPN patients with N0-1 disease achieved 5-year survival, whereas none of the MPD patients with N2-3 disease survived longer than 5 years after surgery.
  
  
  CONCLUSIONS
  The prognosis of patients with surgically detected MPD, who underwent resection, was better than that of M1b patients. MPE patients with N0-1 disease may be candidates for resection.
authors: Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan. tatsurokam@gmail.com
authors: Tatsuro
authors: T
authors: Okamoto
authors: Takekazu
authors: T
authors: Iwata
authors: Teruaki
authors: T
authors: Mizobuchi
authors: Hidehisa
authors: H
authors: Hoshino
authors: Yasumitsu
authors: Y
authors: Moriya
authors: Shigetoshi
authors: S
authors: Yoshida
authors: Ichiro
authors: I
authors: Yoshino
references: J Thorac Oncol. 2007 Aug;2(8):706-14
references: 17762336
references: Chest. 2003 Jan;123(1 Suppl):221S-225S
references: 12527581
references: J Thorac Cardiovasc Surg. 2010 Jun;139(6):1441-6
references: 19939412
references: Ann Thorac Surg. 2000 Apr;69(4):1025-9
references: 10800788
references: Clin Cancer Res. 1997 Jan;3(1):47-50
references: 9815536
references: Ann Thorac Surg. 2005 Jan;79(1):254-7; discussion 254-7
references: 15620952
references: Ann Thorac Surg. 2001 Jun;71(6):1765-71
references: 11426745
references: J Thorac Cardiovasc Surg. 2004 Apr;127(4):1113-8
references: 15052210
references: Lung Cancer. 2001 Oct;34(1):75-81
references: 11557116
references: Ann Thorac Surg. 2002 Feb;73(2):412-5
references: 11845851
references: Surg Today. 2000;30(12):1062-6
references: 11193736
references: Lung Cancer. 2001 Apr;32(1):55-60
references: 11282429
references: J Thorac Cardiovasc Surg. 2003 Dec;126(6):1911-5
references: 14688705
references: Mayo Clin Proc. 2008 Feb;83(2):235-50
references: 18241636